Amicus Therapeutics

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006... Wikipedia

• Type:  Public
• Traded as:  NASDAQ: FOLD, Russell 2000 Component
• Industry:  Biotechnology
• Founded:  February 04, 2002:28
• Key people:  John Crowley (chairman emeritus), Bradley Campbell (president and COO), Daphne Quimi (CFO), David Clark (chief people officer)
• Revenue:  $91,245,000 (2018), $36,930,000 (2017)
• Total assets:  $789,951,000 (2018), $627,024,000 (2017)
• Total equity:  $342,912,000 (2018), $352,850,000 (2017)
• Number of employees:  508 (31 Dec 2018):28
• Data source:  DuckDuckGo